To assess how the mouse model for metastatic colon cancer described in this report reflects these site-specific differences in the tumor microenvironment, we performed immunohistochemistry analysis to detect blood vessels (CD31), macrophages (CD68), and vitronectin. This evidence concerns the gene PECAM1 and neoplasm.